Porous tantalum shell and augment for acetabular defect reconstruction in revision total hip arthroplasty: a mid-term follow-up study
暂无分享,去创建一个
[1] R. Malhotra,et al. Results of trabecular metal augments in Paprosky IIIA and IIIB defects: A MULTICENTRE STUDY , 2018, The bone & joint journal.
[2] R. Bitsch,et al. Comparison of the stability of three fixation techniques between porous metal acetabular components and augments , 2018, Bone & joint research.
[3] A. Hanssen,et al. Minimum Five-Year Outcomes with Porous Tantalum Acetabular Cup and Augment Construct in Complex Revision Total Hip Arthroplasty , 2017, The Journal of bone and joint surgery. American volume.
[4] J. Argenson,et al. Use of porous tantalum components in Paprosky two and three acetabular revision. A minimum five-year follow-up of fifty one hips , 2017, International Orthopaedics.
[5] B. Masri,et al. Porous tantalum uncemented acetabular components in revision total hip arthroplasty: a minimum ten-year clinical, radiological and quality of life outcome study. , 2016, The bone & joint journal.
[6] W. Shon,et al. Acetabular Reconstruction in Total Hip Arthroplasty , 2016, Hip & pelvis.
[7] M. A. Miranda,et al. Use of jumbo cups for revision of acetabulae with large bony defects. , 2010, The Journal of arthroplasty.
[8] D. Backstein,et al. Combined trabecular metal acetabular shell and augment for acetabular revision with substantial bone loss: a mid-term review. , 2013, The bone & joint journal.
[9] Michael J. Christie,et al. Pelvic Discontinuity Treated With Custom Triflange Component: A Reliable Option , 2012, Clinical orthopaedics and related research.
[10] L. Daltroy,et al. The Self-Administered Patient Satisfaction Scale for Primary Hip and Knee Arthroplasty , 2011, Arthritis.
[11] C. McCollough,et al. Bone remodeling around porous metal cementless acetabular components. , 2010, The Journal of arthroplasty.
[12] B. Masri,et al. Modular Tantalum Augments for Acetabular Defects in Revision Hip Arthroplasty , 2009, Clinical orthopaedics and related research.
[13] T. Sculco,et al. Reconstruction of the failed acetabular component using cemented shells and impaction grafting in revision hip arthroplasty. , 2008, American journal of orthopedics.
[14] I. Heyligers,et al. High rate of failure of impaction grafting in large acetabular defects. , 2007, The Journal of bone and joint surgery. British volume.
[15] M. Bostrom,et al. Acetabular Revision with the Contour Antiprotrusio Cage: 2- to 5-Year Followup , 2006, Clinical orthopaedics and related research.
[16] J. Jacobs,et al. Applications of porous tantalum in total hip arthroplasty. , 2006, The Journal of the American Academy of Orthopaedic Surgeons.
[17] S. Sporer,et al. The use of a trabecular metal acetabular component and trabecular metal augment for severe acetabular defects. , 2006, The Journal of arthroplasty.
[18] Joshua J Jacobs,et al. Experimental and clinical performance of porous tantalum in orthopedic surgery. , 2006, Biomaterials.
[19] C. Engh,et al. Radiographic Signs of Osseointegration in Porous-coated Acetabular Components , 2006, Clinical orthopaedics and related research.
[20] A. Gross,et al. The Current Role of Structural Grafts and Cages in Revision Arthroplasty of the Hip , 2004, Clinical orthopaedics and related research.
[21] W. Paprosky,et al. Structural acetabular allograft in revision total hip arthroplasty. , 2002, American journal of orthopedics.
[22] W H Harris,et al. High placement of an acetabular component inserted without cement in a revision total hip arthroplasty. Results after a mean of ten years. , 1999, The Journal of bone and joint surgery. American volume.
[23] Michael Tanzer,et al. Characteristics of bone ingrowth and interface mechanics of a new porous tantalum biomaterial. , 1999, The Journal of bone and joint surgery. British volume.
[24] J. Lawrence,et al. Acetabular defect classification and surgical reconstruction in revision arthroplasty. A 6-year follow-up evaluation. , 1994, The Journal of arthroplasty.
[25] C. Goldsmith,et al. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee. , 1988, The Journal of rheumatology.